JP2024536733A5 - - Google Patents

Info

Publication number
JP2024536733A5
JP2024536733A5 JP2024514688A JP2024514688A JP2024536733A5 JP 2024536733 A5 JP2024536733 A5 JP 2024536733A5 JP 2024514688 A JP2024514688 A JP 2024514688A JP 2024514688 A JP2024514688 A JP 2024514688A JP 2024536733 A5 JP2024536733 A5 JP 2024536733A5
Authority
JP
Japan
Prior art keywords
fusion protein
seq
heteromultimeric
protein
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024514688A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536733A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/074845 external-priority patent/WO2023036814A1/en
Publication of JP2024536733A publication Critical patent/JP2024536733A/ja
Publication of JP2024536733A5 publication Critical patent/JP2024536733A5/ja
Pending legal-status Critical Current

Links

JP2024514688A 2021-09-07 2022-09-07 コロナウイルス融合タンパク質 Pending JP2024536733A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21306220.1 2021-09-07
EP21306220 2021-09-07
PCT/EP2022/074845 WO2023036814A1 (en) 2021-09-07 2022-09-07 Coronavirus fusion protein

Publications (2)

Publication Number Publication Date
JP2024536733A JP2024536733A (ja) 2024-10-08
JP2024536733A5 true JP2024536733A5 (https=) 2025-09-16

Family

ID=78332732

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024514688A Pending JP2024536733A (ja) 2021-09-07 2022-09-07 コロナウイルス融合タンパク質

Country Status (4)

Country Link
US (1) US20240424086A1 (https=)
EP (1) EP4399219A1 (https=)
JP (1) JP2024536733A (https=)
WO (1) WO2023036814A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
US5350674A (en) 1992-09-04 1994-09-27 Becton, Dickinson And Company Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
FR2815870A1 (fr) 2000-10-27 2002-05-03 Biovector Therapeutics Utilisation de particules hydrophiles associees a des antigenes identiques ou differents pour la preparation de compositions de vaccin
CN100386343C (zh) * 2003-07-03 2008-05-07 李越希 Sars病毒s蛋白与n蛋白的融合蛋白及其制备、应用
IL295548A (en) * 2020-02-14 2022-10-01 Altimmune Inc Immunogenic compositions of the corona virus and their uses
CN111187354B (zh) * 2020-02-20 2020-11-27 北京新创生物工程有限公司 新型冠状病毒(SARS-CoV-2)IgM/IgG抗体检测试剂盒

Similar Documents

Publication Publication Date Title
JP2023018073A5 (https=)
US20250171501A1 (en) A subunit vaccine for treatment or prevention of a respiratory tract infection
JP2023522249A5 (https=)
ES2839880T3 (es) Vacuna contra el VRS
IL321500A (en) Pre-stabilized hmpv f proteins
RU2468080C2 (ru) Новый класс терапевтических белковых молекул
JP2023506765A5 (https=)
CN113264990B (zh) 抑制新型冠状病毒(sars-cov-2)的多肽和其应用
FI3606942T3 (fi) Itsejärjestyviä proteiininanorakenteita, jotka esittävät paramyksovirus- ja/tai pneumovirus f -proteiineja ja niiden käyttö
WO2022206222A1 (zh) 一种新型冠状病毒s-rbd三聚体蛋白疫苗、其制备方法和应用
EA017957B1 (ru) Композиции и способы, ингибирующие грипп
JP2023532290A5 (https=)
JP2023522154A5 (https=)
JP7009625B2 (ja) Ｈ３ｎ２亜型インフルエンザウイルスのヘマグルチニンタンパク質の突然変異体及びその使用
EP1797112B1 (en) Inhibitors of hepatitits c virus
JP2024536733A5 (https=)
JP6373601B2 (ja) アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド
US20240261389A1 (en) Amino acids, nucleotides and vectors expressing the same and uses thereof in preventing sarbecovirus infection
JP2024518548A5 (https=)
RU2005123050A (ru) Супер-антигенные фьюжн-белки и их использование
CN118684738A (zh) 靶向人呼吸道合胞病毒融合糖蛋白的多肽拮抗剂
WO2024192698A1 (zh) 靶向人呼吸道合胞病毒融合糖蛋白的多肽拮抗剂
Wang et al. Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins
RU2023114392A (ru) Днк-кодированные наночастицы и способ их применения в качестве вакцины от коронавирусного заболевания 2019 (covid-19)
KR20260035821A (ko) 조작된 gcn4 삼량체화 모티프